Randall Stuewe
Analyst · Goldman Sachs.
I knew you were going to do that. No. But the answer is we think feed will -- obviously, that's the largest segment. We should see a pretty nice improvement. The $57 million, $58 million fourth quarter should not be repeated. As we said, with all the one-timers that flew through at the -- that Brad mentioned in his comments, clearly, a full year of our Amparo, Peptan plant running is going to help us. The -- we had a pretty nice performance in China last year in our food segment, I think we'll be okay there this year. A little hesitation in this. Comments are that it's very challenging over there but at the end of the day, all 3 of our [indiscerinible] plants are running today in China, and that's a domestic business. And then I commented, we have bringing up in order, we have our Angouleme, Ghent and [indiscerinible] Peptan plant, all coming online starting up in April, May and June, concurrently with production to the market in May, June, July. So the Food segment, as we said, will show some very nice growth, but it will be back half loaded as we go forward, much as John talks about renewable diesel demand, we continue to see very nice and significant growth in the hydrolyzed collagen business around the world and sports, health and nutrition markets. So clearly, it's going to -- as we said, the Feed or Food or Fuel segments always kind of an annuity out there. The difference this year versus last year will be the prospective tax credit. But as you were asking, and I'm just throwing a few more color comments in here for you. While John was talking about renewable diesel and the demand and margin structure, the margin structure post BTC for the classic biodiesel business is not good. And you -- I want to say that the earnings in the classic biodiesel business that we operate today and fairly competitive plants are somewhere between 0 and $0.10 gallon black right now, even with the dollar again. The RIN market did not react, the feedstocks, as we talked about, moved up the HOBO spread kind of went crazy. So that's really not a very good business. That will weigh a little bit on our Canadian operation. But overall, we should be able to make it up. So long story short, we think the low sides $450, we think we get any type of pricing authority. $475 plus is doable and making sure that those Peptan plants come up online. I think we're positioned even to go higher in 2021.